Business Context and Reporting Period
Company: InspireMD, Inc. (NSPR)
Filing Type: Form 8-K (Current Report)
Date of Report: November 4, 2025
Reporting Period: The filing announces financial and operating results for the three and nine months ended September 30, 2025.
Key Financial Metrics
The provided Form 8-K text serves as a notification of results and does not contain specific numerical data. The filing states that detailed financial metrics—including revenue, profit, cash flow, margins, debt, and liquidity—are contained within the attached press release (Exhibit 99.1) and investor presentation (Exhibit 99.2). Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing does not detail specific material changes versus prior periods. It references the attached press release for a discussion of recent highlights and operating results for the periods ended September 30, 2025.
Guidance, Outlook, and Risks
Outlook and Commentary: The Company made available an updated investor presentation on November 4, 2025, which is incorporated by reference. Specific guidance or management commentary is not included in the text of this 8-K.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text. The document notes that information furnished under Items 2.02 and 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and nine months ended September 30, 2025.
- Examine Exhibit 99.2 (Investor Presentation) for updated business outlook, strategic highlights, and forward-looking statements.
- Verify the Company's liquidity position and debt obligations as detailed in the attached exhibits, as these are not present in the 8-K summary text.
- Confirm the trading status of Common Stock (NSPR) on The Nasdaq Capital Market LLC.